Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Exp Neurol. 2017 Apr 12;293:144–158. doi: 10.1016/j.expneurol.2017.04.004

Figure 8.

Figure 8

Summary of plasma membrane levels of GluA1 and GluA2 after treatment. Rats were treated with saline, carrageenan, or carrageenan and i.t. inhibitors of NMDAR, PKA, PI3K, or TNF. Mean ± SEM from each treatment group is graphed as a percentage of saline/vehicle controls indicated as the origin on graph.